Drew Elizabeth McCormick
Subscribe to Drew Elizabeth McCormick's PostsDrew Elizabeth McCormick maintains a general health industry and regulatory practice. Drew advises health care clients on a wide variety of health care regulatory issues, including Medicare and Medicaid regulations, the Federal Anti-Kickback Statute, Ethics in Patient Referral Law, False Claims Act and Health Insurance Portability and Accountability Act (HIPAA), as well as state fraud and abuse laws, privacy laws, licensure regulation, research regulation, and health care compliance matters. Drew also has experience counseling clients who are undergoing government audits and investigations. Read Drew Elizabeth McCormicks' full bio.
New Illinois Protections Against Patient Medical Debt May Also Help Reduce Hospital Bad Debt
By Sumaya Noush, Gregory Fosheim and Drew Elizabeth McCormick on Jan 9, 2024
Posted In Employee Benefits, Health and Welfare Plans
The Protect Illinoisans from Unfair Medical Debt bill will require Illinois hospitals to take a much more active role in limiting consumers’ medical debt. The bill puts into place four primary requirements designed to reduce the medical debt burden of individuals receiving care. These requirements will apply to services provided on or after June 29,...
Continue Reading
Departments Issue Final Rule Implementing Certain No Surprises Act Provisions
By Brian Stimson, Jamie Gelfman, Drew Elizabeth McCormick and Emily Curran on Sep 14, 2022
Posted In Employee Benefits, Health and Welfare Plans
On August 19, 2022, the US Departments of Health and Human Services (HHS), Labor and Treasury posted a final rule revising portions of the federal No Surprises Act (NSA). Generally, the rule finalizes three aspects of the two-part interim final rule that the Departments published along with the Office of Personnel Management in 2021. First,...
Continue Reading
Supreme Court Agrees to Review Medicare Payment Cuts to 340B Drugs
By Drew Elizabeth McCormick and Emily J. Cook on Oct 19, 2021
Posted In Employee Benefits, Health and Welfare Plans
The US Supreme Court announced in July that it will take up review of the decision by the US Court of Appeals for the District of Columbia Circuit upholding Medicare’s 2018 payment cuts to 340B drugs. The case will be closely watched, given its potentially far-reaching impacts on reimbursements to most hospitals that participate in...
Continue Reading
Court Issues Permanent Injunction Blocking Medicare 340B Payment Cuts
By Drew Elizabeth McCormick, Emily J. Cook, Eric Zimmerman and Steven J. Schnelle on Jan 22, 2019
Posted In Employee Benefits, Health and Welfare Plans
The US District Court for the District of Columbia recently held that the Centers for Medicare and Medicaid Services (CMS) exceeded its authority by reducing Medicare payment rates for 340B drugs, but, because of the budget-neutral nature of the cuts, the court left implementation details of its order temporarily unresolved to avoid disrupting administration of...
Continue Reading
